You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nilotinib

Showing 76 - 100 of 252
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)

Recruiting
  • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
  • Longmont, Colorado
  • +128 more
Aug 1, 2022

Condition Vasoregulation Function Endothelium in CML Getting TKI

Recruiting
  • Chronic Myeloid Leukaemia
  • taking blood for the study of biochemical parameters and the study of microcirculation using the method of laser Doppler flowmetry
  • Moscow, Russian Federation
  • +1 more
Jan 11, 2023

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Asciminib single agent
  • +5 more
  • Ann Arbor, Michigan
  • +49 more
Jan 26, 2023

Leukemia, Myelogenous, Chronic Trial in Houston (Nilotinib)

Completed
Has Results
  • Leukemia, Myelogenous, Chronic
  • Nilotinib
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 16, 2019

Chronyc Myeloid Leukemia Trial in Italy, Netherlands (Imatinib, Nilotinib)

Active, not recruiting
  • Chronyc Myeloid Leukemia
  • Alessandria, Italy
  • +81 more
Jan 4, 2022

Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission, Minimal Residual

Terminated
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2020

Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia

Not yet recruiting
  • Tyrosine Kinase Inhibitor
  • +2 more
    • Taipei, Taiwan
      National Taiwan University Hospital
    Feb 17, 2022

    Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)

    Recruiting
    • Cancer
    • +3 more
    • Amersfoort, Utrecht, Netherlands
    • +34 more
    Oct 26, 2021

    Withdrawal of Second-generation Tyrosine Kinase Inhibitors After

    Recruiting
    • MMR on 12 Month
    • Guangzhou, Guangdong, China
    • +1 more
    Apr 21, 2022

    Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Trial in Worldwide (Nilotinib)

    Completed
    Has Results
    • Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
    • Nilotinib
    • Linz, Oberoesterreich, Austria
    • +207 more
    Jun 23, 2021

    Philadelphia Chromsome Positive Acute Lymphoblastic Leukemia Trial in France, Germany, Spain (Nilotinib)

    Completed
    • Philadelphia Chromsome Positive Acute Lymphoblastic Leukemia
    • Nilotinib
    • Aix-en-Provence cedex 1, France
    • +68 more
    Jul 29, 2020

    Withdrawal or Reduction TKIs in CML-CP

    Recruiting
    • MMR on 12 Month
    • withdrawal TKIs or halve TKIs
    • Guangzhou, Guangdong, China
      NanfangH
    Sep 2, 2021

    Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia Trial in Paris (Nilotinib, Methotrexate, Aracytine (Ara C))

    Recruiting
    • Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia
    • Nilotinib
    • +8 more
    • Paris, France
      Hopital Saint Louis
    Oct 18, 2019

    Leukemia Trial in China (Imatinib, Nilotinib)

    Completed
    Has Results
    • Leukemia
    • Guangzhou, Guangdong, China
    • +11 more
    Jul 11, 2019

    Leukemia, Myeloid, Chronic-Phase Trial in Germany (Ponatinib)

    Active, not recruiting
    • Leukemia, Myeloid, Chronic-Phase
    • Halle (Saale), Saxony-Anhalt, Germany
    • +9 more
    Sep 9, 2022

    Chronic Myeloid Leukemia Trial in Germany (Imatinib, Nilotinib)

    Terminated
    • Chronic Myeloid Leukemia
    • Aachen, Germany
    • +17 more
    Nov 27, 2019

    Parkinson Disease, Parkinsons Disease With Dementia Trial in Washington (Placebo Oral Capsule, Nilotinib 150mg oral capsule

    Unknown status
    • Parkinson Disease
    • Parkinsons Disease With Dementia
    • Placebo Oral Capsule
    • +2 more
    • Washington, District of Columbia
      MedStar Georgetown University Hospital
    Mar 13, 2019

    Chronic Myelogenous Leukemia Trial in Lyon (Nilotinib,Novartis,300 mg twice a day +Pegylated interferon 2a,Roche, 45 microg

    Completed
    • Chronic Myelogenous Leukemia
    • Nilotinib,Novartis,300 mg twice a day +Pegylated interferon 2a,Roche, 45 microg weekly starting Month 2-Month 12 or beyond according to investigator choice.
    • Lyon, France
      Hospices Civils de Lyon
    May 23, 2019

    Concomitant Medications at CML Diagnosis

    Completed
    • Chronic Myeloid Leukemia
    • the prevalence of comorbid conditions
    • (no location specified)
    Sep 16, 2023

    Alzheimer's Disease Trial in Washington (Placebo Capsule(s) Once a Day by Mouth, Nilotinib Capsule(s) Once a Day by Mouth)

    Unknown status
    • Alzheimer's Disease
    • Placebo Capsule(s) Once a Day by Mouth
    • Nilotinib Capsule(s) Once a Day by Mouth
    • Washington, District of Columbia
      Georgetown University Medical Center
    Mar 12, 2019

    Chronic Myeloid Leukemia Trial in Germany (Nilotinib, Ruxolitinib)

    Completed
    • Chronic Myeloid Leukemia
    • Berlin, Germany
    • +3 more
    Apr 29, 2019

    Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1,

    Completed
    Has Results
    • Adult Acute Lymphoblastic Leukemia in Remission
    • +9 more
    • Denver, Colorado
    • +2 more
    Jan 17, 2020

    Chronic Myelogenous Leukemia Patients Treated With Imatinib

    Recruiting
    • Chronic Myelogenous Leukemia
    • Chart Review
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Feb 8, 2022

    GVHD Trial in Belgium, France (Imatinib Mesylate and Nilotinib)

    Completed
    • Graft Versus Host Disease
    • Imatinib Mesylate and Nilotinib
    • Liège, Belgium
    • +21 more
    Jul 9, 2019

    CML Trial in United States (nilotinib)

    Completed
    Has Results
    • CML
    • nilotinib
    • Birmingham, Alabama
    • +53 more
    Feb 25, 2020